Text

Phase IV studies

---

For new drugs or vaccines, the evidence from one or more Phase III trials, taken together with the results of the Phase
I and II trials, will be presented to licensing authorities to register the product for clinical or public health use.
However, the total number of participants included in Phase I to III trials of a new product will often be no more than
a few thousand, and there are usually important public health issues that will have been incompletely addressed at the
time a product is licensed.

---

Availability

No copy data

Detail Information

Series Title

-

Call Number

-

Publisher

: Oxford University Press., 2015

Collation

480

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

text

Media Type

computer

Carrier Type

online resource

Edition

-

Subject(s)

sports
Phase IV studies

Specific Detail Info

-

Statement of Responsibility

-

Other Information

Cataloger

Angga

Source

-

Validator

-

Digital Object Identifier (DOI)

https://directory.doabooks.org/handle/20.500.12854/33332

Journal Volume

-

Journal Issue

-

Subtitle

-

Parallel Title

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment